November 19, 2024- Abbott marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony attended by An Taoiseach, Simon Harris, TD, and Abbott Chairman and Chief Executive Officer, Robert Ford. The site is a global manufacturing center of excellence for Abbott’s diabetes care business and will employ more than 800 people.
The Kilkenny facility is part of a €440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created. The new 30,000-square meter Kilkenny facility is producing FreeStyle Libre 3 sensors, the world’s smallest sensors and latest generation in Abbott’s world-leading2 continuous glucose monitoring portfolio for people living with diabetes.